Regular ArticleStructure and Methylation-Based Silencing of a Gene (DBCCR1) within a Candidate Bladder Cancer Tumor Suppressor Region at 9q32–q33
References (55)
- et al.
Basic local alignment search tool
J. Mol. Biol.
(1990) - et al.
A case of transitional cell carcinoma of the bladder with a del(9)(q11q21.2)
Cancer Genet. Cytogenet.
(1993) - et al.
CpG islands and genes
Curr. Opin. Genet. Dev.
(1995) - et al.
Genetic alterations in bladder cancer
Lancet
(1993) - et al.
CpG islands in vertebrate genomes
J. Mol. Biol.
(1987) Structual features in eukaryotic mRNAs that modulate the initiation of translation
J. Biol. Chem.
(1991)- et al.
The I.M.A.G.E. consortium: An integrated molecular analysis of genomes and their expression
Genomics
(1996) - et al.
Structure and methylation-associated silencing of a gene within a homozygously deleted region of human chromosome band 8p22
Genomics
(1996) - et al.
Chromosomal analysis of bladder cancer. III. Nonrandom alterations
Cancer Genet. Cytogenet.
(1987) - et al.
Cytogenetic investigation on 30 bladder carcinomas
Cancer Genet. Cytogenet.
(1988)
An allelotype of squamous carcinoma of the head and neck using microsatellite markers
Cancer Res.
PROSITE: A dictionary of sites and patterns in proteins
Nucleic Acids Res.
Gene-based sequence- tagged-sites (STSs) as the basis for a human gene map
Nat. Genet.
Frequency of homozygous deletion atp16/CDKN2
Nat. Genet.
Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas
Cancer Res.
The short arm of chromosome 11 is a “hot spot” for hypermethylation in human neoplasia
Proc. Natl. Acad. Sci. USA
High frequency of chromosome 9 deletion in ovarian cancer: Evidence for three tumour-suppressor loci
Br. J. Cancer
Methylation of the 5′ CpG island of thep16/CDKN1
Cancer Res.
Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma
Hum. Genet.
Accumulated allelic losses in the development of invasive urothelial cancer
Int. J. Cancer
Detailed deletion mapping of chromosome 9q in bladder cancer: Evidence for two tumour suppressor loci
Oncogene
A novel candidate tumour suppressor locus at 9q32–33 in bladder cancer: Localisation of the candidate region within a single 840 kb YAC
Hum. Mol. Genet.
The DCC gene product in cellular differentiation and colorectal tumorigenesis
Genes Dev.
Silencing fo the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
Proc. Natl. Acad. Sci. USA
Inactivation of theCDKN2/p16/MTS1
Cancer Res.
Hypermethylation associated inactivation indicates a tumor suppressor role forp15INK4B.
Cancer Res.
Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon
Nat. Genet.
Cited by (124)
Neurodevelopmental MACPFs: The vertebrate astrotactins and BRINPs
2017, Seminars in Cell and Developmental BiologyCitation Excerpt :BRINP3 is overexpressed in pituitary adenomas and overexpression of BRINP3 in gonadotrope cell pituitary adenomas results in increased proliferation, migration and invasion [75]. Intriguingly, despite the very low level of expression in non-neuronal tissue [12,76], all three BRINPs have also been implicated in several different forms of non-neuronal cancer [48,49,77,78]. Additionally, BRINP2 and BRINP3 are associated with coronary heart disease [79,80] and BRINP3 (FAM5C) is a candidate gene for aggressive periodontitis [81].
MACPF/CDC proteins in development: Insights from Drosophila torso-like
2017, Seminars in Cell and Developmental BiologyMolecular genesis of non-muscle-invasive urothelial carcinoma (NMIUC)
2010, Expert Reviews in Molecular MedicineMethylation in the promoter regions of WT1, NKX6-1 AND DBC1 genes in cervical cancer tissues of Uygur women in Xinjiang
2018, Genetics and Molecular Biology
- 1
Present address: Department of Urology, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Sakyo-ku, Kyoto 606, Japan.
- 2
To whom correspondence should be addressed at ICRF Cancer Medicine Research Unit, St. James's University Hospital, Beckett Street, Leeds, LS9 7TF, UK. Telephone: 44-0113-2064913. Fax: 44-0113-2429886. E-mail:[email protected].